MEK Inhibitor AZD6244 With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery
This study is ongoing, but not recruiting participants.
Study NCT01206140
Information provided by National Cancer Institute (NCI)
First Received on September 18, 2010.
Last Updated on June 17, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
